JPRN-UMIN000032096已完成未知
Combined therapy with immune-suppressive drug in children with immunoglobulin resistant Kawasaki disease - Combined therapy with IFX and CICyA in KD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 15years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •shock or oversensitivity of asprin, immunoglobulin, infliximab, and cyclosporin A. low contraction at left ventricle (FS<0.28) low renal function (creatinine <0.9mg/dl or estimated GFR<50ml/min/1.73m2) Contraindication of infliximab and cyclosporin A. Liver dysfunction (AST or ALT >500 U/L) before continuos infusion of cyclosporin A. Critical active bacterial infection before therapy.
研究者
相似试验
已完成
不适用
Study of combination immunosuppressive therapy in primary sclerosing cholangitis - A multicenter study for combination immunosuppressive therapy with mizoribine and azathioprinePrimary sclerosing cholangitisJPRN-UMIN000029482Osaka General Medical Center6
已完成
不适用
Combination therapy of immuno checkpoint inhibitors and radiosensitization treatment for metastatic melanomaJPRN-UMIN000026925Kochi University, Kochi Medical School5
已完成
1 期
A combination immunotherapy for the patients with advanced or metastatic solid cancersolid cancerJPRN-UMIN000020440Yamaguchi university Graduate School of Medicine17
进行中（未招募）
不适用
INDUCTION TREATMENT FOLLOWED BY IMMUNOSUPPRESSION WITHDRAWAL IN LIVER TRANSPLANTATION: A COMPARATIVE TRIAL.Tratamiento de inducción y retirada de la inmunosupresión en el trasplante hepático. Estudio comparativo - ATEGE_LIVERiver transplantationEUCTR2005-005635-10-ESiver Unit, ICMD, Hospital Clinic Barcelona
尚未招募
不适用
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)on Small Cell Lung CancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesRPCEC00000270Center of Molecular Immunology (CIM)30